Hardik Mody

Hardik Mody is a Principal Scientist specializing in Clinical Pharmacology at Genentech since January 2023, with a strong background in pharmacokinetics and pharmacodynamics (PK/PD) across various therapeutic areas. Prior to this role, Hardik served as Principal Scientist in PK/PD at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2019 to January 2023, leading translational efforts for diverse drug modalities and contributing significantly to development strategies. Previous positions include Senior Scientist and Scientist in PK/PD (Biologics) as well as Postdoctoral Associate at the Center for Pharmacometrics & Systems Pharmacology at the University of Florida, where Hardik worked on multi-scale pharmacokinetic models. Hardik holds a PhD and an MS in Pharmaceutical Sciences from The Ohio State University and a BPharm from the University of Mumbai, with research focused on micro-RNA roles in pancreatic cancer.